ARA-290
An erythropoietin-derived peptide (cibinetide) studied in clinical trials on nerve-related pain. Not FDA-approved.
- Type
- Peptide
- Research area
- Recovery research
- Research stage
- Clinical trials
- FDA status
- Not an FDA-approved medicine
About ARA-290
An erythropoietin-derived peptide (cibinetide) studied in clinical trials on nerve-related pain. Not FDA-approved.
Where the research stands
Most published work on this compound comes from laboratory, animal or early human studies. Results in those settings don't always carry over to people, and long-term safety data are limited.
Read the studies
Educational information only; not medical advice. Talk to a licensed doctor before using any compound.
Related compounds
B7-33B7-33
A synthetic peptide derived from relaxin-2, studied in laboratory and animal research on fibrosis.
BPC-157BPC-157
A stomach-protein fragment studied mainly in animal models of tissue healing.
TB-500TB-500
A synthetic fragment of thymosin beta-4 studied in cell and animal research.